Mangiferin (7) downregulated TNF-α, IL-1β, and IFN-γ expression in TNF-α-stimulated CD3− synovial cells from rheumatoid arthritis (RA) patients, which indicated that mangiferin could be a potent candidate for the treatment of RA [46]. This evidence concerns the gene IL1B and rheumatoid arthritis.